Clinical Diagnostics Technology & Disease Research News | 360Dx
Emerging economic and technological trends in the clinical diagnostic market. Diagnostics market and reports on regulatory, reimbursement, and policy issues that impact the commercial operations of clinical labs.
About Us - 360Dx
GenomeWeb Crain Communications, Inc. 685 Third Avenue New York, NY 10017 T: 212-210-0100
360Dx Subscription Options | 360Dx
360Dx is the leading source for breaking news and in-depth analysis on the clinical lab and in vitro diagnostics markets. A free 360Dx account gives you instant access to real-time reporting on the lab industry while a Premium account provides the very best of our science, business, and technology journalism.
Diagnostic Technologies and Applications - 360Dx
News and analysis on diagnostic technologies and applications from 360Dx.
FDA Rule on LDTs Dominates Clinical Lab Landscape in 2024
2 天之前 · NEW YORK – For clinical labs, 2024 will most likely be remembered as the year the US Food and Drug Administration finally made good on its decades-old promise — or threat, depending on your point of view — to regulate laboratory-developed tests (LDTs).
360Dx Top 30 Rises 3 Percent in May
2024年6月4日 · NEW YORK – Rebounding from a 6 percent tumble in April, the 360Dx Top 30 rose nearly 3 percent in May. The Top 30 reflected broader market trends as the Dow Jones Industrial Average rose 2 percent and the Nasdaq grew 7 percent last month, while the Nasdaq Biotech Index increased 6 percent month over month.
Mixed Month for Diagnostics Stocks as 360Dx Top 30 Ticks up 1 …
2024年12月2日 · NEW YORK – After a 3 percent decline in October, the 360Dx Top 30 has reversed course, rising 1 percent in November. The Top 30 trailed the performance of the Dow Jones Industrial Average, which rose nearly 8 percent, and the Nasdaq, which was up 6 percent. The Nasdaq Biotech Index, meanwhile, was ...
360Dx Top 30 Slides 1 Percent in January
2024年1月31日 · Note: The 360Dx Top 30 has been updated with new entries Biodesix, MDxHealth, OraSure Technologies, and Sera Prognostics based on market cap as of beginning of trading in January 2024.
New Products Diagnostics News - 360Dx
2024年11月1日 · Nonacus has launched a research-use-only qPCR kit to detect ESR1 mutations. The Galeas uPCR ESR1 kit is an ultrasensitive qPCR assay developed to detect eleven mutations in the ESR1 gene known to be associated with resistance to endocrine therapy, a common treatment for certain types of breast cancer. uPCR is a novel method developed by Nonacus that increases the sensitivity and specificity of ...
Frequently Asked Questions - 360Dx
What is 360Dx? 360Dx, launched in 2016, covers emerging economic and technological trends in the clinical diagnostic market. Our dedicated online newsroom tracks the biggest players in the diagnostics market and reports on regulatory, reimbursement, and policy issues that impact the commercial operations of clinical labs.